{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:20:11Z","timestamp":1790932811164,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/mao.0b013e31816021f7","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T01:30:17Z","timestamp":1236216617000},"page":"58-68","source":"Crossref","is-referenced-by-count":49,"title":["Phosphatidylinositol 3-Kinase\/AKT Pathway Activation in Human Vestibular Schwannoma"],"prefix":"10.1097","volume":"29","author":[{"given":"Abraham","family":"Jacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina X.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyra","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley D.","family":"Welling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20221010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00005537-199802000-00005","article-title":"Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).","volume":"108","author":"Welling","year":"1998","journal-title":"Laryngoscope"},{"key":"R2-13-20221010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane organizing protein causes neuro-fibromatosis type 2.","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"R3-13-20221010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2tumor suppressor published erratum appears in Cell 1993;75:826.","volume":"72","author":"Trofatter","year":"1993","journal-title":"Cell"},{"key":"R4-13-20221010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/nbdi.1997.0128","article-title":"Minsights into neurofibromatosis 2.","volume":"3","author":"Gutmann","year":"1997","journal-title":"Neurobiol Dis"},{"key":"R5-13-20221010","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","article-title":"Interdomain binding mediates tumor growth suppression by the NF2 gene product.","volume":"15","author":"Sherman","year":"1996","journal-title":"Oncogene"},{"key":"R6-13-20221010","first-page":"73","article-title":"Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.","volume":"13","author":"Huynh","year":"1996","journal-title":"Oncogene"},{"key":"R7-13-20221010","doi-asserted-by":"crossref","first-page":"34438","DOI":"10.1074\/jbc.274.48.34438","article-title":"Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF.","volume":"274","author":"Gonzalez-Agosti","year":"1999","journal-title":"J Biol Chem"},{"key":"R9-13-20221010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3171\/jns.2005.103.1.0059","article-title":"Systematic review of the natural history of vestibular schwannoma.","volume":"103","author":"Yoshimoto","year":"2005","journal-title":"J Neurosurg"},{"key":"R10-13-20221010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0092-8674(00)00110-0","article-title":"Cellular signaling: pivoting around PDK-1.","volume":"103","author":"Toker","year":"2000","journal-title":"Cell"},{"key":"R11-13-20221010","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer.","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"R12-13-20221010","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1158\/0008-5472.CAN-06-0743","article-title":"Akt signaling and cancer: surviving but not moving on.","volume":"66","author":"Toker","year":"2006","journal-title":"Cancer Res"},{"key":"R13-13-20221010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcdb.2003.12.022","article-title":"PDK1, the master regulator of AGC kinase signal transduction.","volume":"15","author":"Mora","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"R14-13-20221010","doi-asserted-by":"crossref","first-page":"E187","DOI":"10.1152\/ajpendo.00011.2005","article-title":"PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle.","volume":"289","author":"Dong","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R15-13-20221010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2006.02.024","article-title":"Regulation of the PTEN phosphatase.","volume":"374","author":"Gericke","year":"2006","journal-title":"Gene"},{"key":"R16-13-20221010","doi-asserted-by":"crossref","first-page":"35195","DOI":"10.1074\/jbc.M503045200","article-title":"Cooperative phosphorylation of the tumor suppressor phosphatase (PTEN) by casein kinases and glycogen synthase kinase 3?","volume":"280","author":"Al-Khouri","year":"2005","journal-title":"J Biol Chem"},{"key":"R17-13-20221010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0065-230X(05)94002-5","article-title":"Activation of AKT kinases in cancer: implications for therapeutic targeting.","volume":"94","author":"Bellacosa","year":"2005","journal-title":"Adv Cancer Res"},{"key":"R18-13-20221010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1101\/gad.14.2.142","article-title":"Unified nomenclature for the winged helix\/forkhead transcription factors.","volume":"14","author":"Kaestner","year":"2000","journal-title":"Genes Dev"},{"key":"R19-13-20221010","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","article-title":"FOXO transcription factors at the interface between longevity and tumor suppression.","volume":"24","author":"Greer","year":"2005","journal-title":"Oncogene"},{"key":"R20-13-20221010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3 in cellular signaling.","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog Neurobiol"},{"key":"R22-13-20221010","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.282.5392.1318","article-title":"Regulation of cell death protease caspase-9 by phosphorylation.","volume":"282","author":"Cardone","year":"1998","journal-title":"Science"},{"key":"R23-13-20221010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","article-title":"AKT phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.","volume":"91","author":"Datta","year":"1997","journal-title":"Cell"},{"key":"R24-13-20221010","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1073\/pnas.0405971102","article-title":"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.","volume":"101","author":"Rong","year":"2004","journal-title":"PNAS"},{"key":"R25-13-20221010","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/nn1134","article-title":"PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis.","volume":"6","author":"Rong","year":"2003","journal-title":"Nat Neurosci"},{"key":"R27-13-20221010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1006\/mcne.2000.0967","article-title":"Neuregulin signaling through a PI3K\/Akt\/Bad pathway in Schwann cell survival.","volume":"17","author":"Li","year":"2001","journal-title":"Mol Cell Neurosci"},{"key":"R28-13-20221010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0303-7207(00)00324-5","article-title":"IGF-1 promotes Schwann cell motility and survival via activation of AKT.","volume":"170","author":"Cheng","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"R29-13-20221010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/glia.20330","article-title":"Cyclic AMP synergistically enhances neuregulin-dependnet ERK and Akt activation and cell cycle progression in Schwann cells.","volume":"53","author":"Monje","year":"2006","journal-title":"Glia"},{"key":"R30-13-20221010","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex.","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"R31-13-20221010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"key":"R32-13-20221010","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat Cell Biol"},{"key":"R33-13-20221010","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"R34-13-20221010","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/MCB.16.4.1722","article-title":"Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction.","volume":"16","author":"Wymann","year":"1996","journal-title":"Mol Cell Biol"},{"key":"R35-13-20221010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.2005.05881.x","article-title":"Inhibition of the phosphatidylinositol-3 kinase\/AKT promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma.","volume":"132","author":"Georgakis","year":"2005","journal-title":"Br J Haematol"},{"key":"R36-13-20221010","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-04-0343","article-title":"Akt\/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res"},{"key":"R39-13-20221010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd2062","article-title":"Current development of mTOR inhibitors as anticancer agents.","volume":"5","author":"Faivre","year":"2006","journal-title":"Nature Rev Drug Discov"},{"key":"R40-13-20221010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1158\/0008-5472.CAN-3554-2","article-title":"Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells.","volume":"64","author":"Boulay","year":"2004","journal-title":"Cancer Res"},{"key":"R41-13-20221010","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/0008-5472.CAN-03-4063","article-title":"From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors.","volume":"64","author":"Zhu","year":"2004","journal-title":"Cancer Res"},{"key":"R42-13-20221010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.gassur.2005.07.025","article-title":"A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth.","volume":"10","author":"Li","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"R43-13-20221010","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2004-05-1957","article-title":"A novel celecoxib derivative, OSU-03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanism.","volume":"105","author":"Johnson","year":"2005","journal-title":"Blood"},{"key":"R44-13-20221010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1124\/mol.106.026252","article-title":"OSU-03012 in the treatment of glioblastoma.","volume":"70","author":"McCubrey","year":"2006","journal-title":"Mol Pharmacol"},{"key":"R45-13-20221010","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1186\/bcr1294","article-title":"Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours.","volume":"7","author":"Kucab","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R46-13-20221010","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1097\/01.mlg.0000240185.14224.7d","article-title":"Growth of benign and malignant schwannoma xenografts in severe combined immunodeficiency mice.","volume":"116","author":"Chang","year":"2006","journal-title":"Laryngoscope"}],"container-title":["Otology & Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00129492-200801000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:58Z","timestamp":1786038538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00129492-200801000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mao.0b013e31816021f7","relation":{},"ISSN":["1531-7129"],"issn-type":[{"value":"1531-7129","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}